The table below shows BIO-TECHNE Corp's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Operating cash flow
$292.07M
$287.56M
$298.98M
$254.39M
$325.27M
$352.16M
Capital expenditure
$28.85M
$31.01M
$62.88M
$38.24M
$44.91M
$44.30M
Investing cash flow
-$18.19M
-$35.18M
-$203.03M
-$265.65M
-$96.85M
-$243.52M
Dividends paid
$49.92M
$50.39M
$50.42M
$50.28M
TECH operating cash flow (10-K history)
BIO-TECHNE Corp reported operating cash flow of $292.07M for fiscal year 2026. That is up 1.6% from $287.56M in fiscal 2025. Over the 10 fiscal years shown, operating cash flow grew from $143.72M (FY 2017) to $292.07M. Figures come from the company's audited annual reports as filed with the SEC.
